SCHEMBL1268669

SCHEMBL1268669

CCc1nc(NS(=O)(=O)c2ccc(C(F)(F)F)cc2Cl)ccc1Sc1ccc(S(=O)(=O)N2CCOCC2)cc1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.45
▸ PKM P14618 1/20 0.45
▸ EPHX2 P34913 1/20 0.41
▸ MAPT P10636 2/20 0.38
▸ HTT P42858 2/20 0.38
▸ KMT2A Q03164 1/20 0.37
▸ USP2 O75604 1/20 0.37
▸ SCN9A Q15858 5/20 0.37
▸ TP53 P04637 1/20 0.37
▸ LMNA P02545 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ MCOLN3 Q8TDD5 1/20 0.37
▸ GLA P06280 1/20 0.36
▸ ABCC9 O60706 1/20 0.36
▸ ABCC8 Q09428 1/20 0.36
▸ KCNJ11 Q14654 1/20 0.36
▸ KCNJ8 Q15842 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1269489 0.93 GAA (0.43) GAAPKMEPHX2MAPTHTT
SCHEMBL1268674 0.91 GAA (0.42) GAAPKMEPHX2MAPTHTT
SCHEMBL1268685 0.90 GAA (0.43) GAAPKMEPHX2MAPTHTT
SCHEMBL1269670 0.90 KMT2A (0.42) GAAMAPTHTTKMT2AUSP2
SCHEMBL1269830 0.88 GAA (0.43) GAAPKMEPHX2MAPTHTT
SCHEMBL1268625 0.85 ALDH1A1 (0.39) GAAPKMMAPTHTTKMT2A
SCHEMBL1269770 0.84 GAA (0.42) GAAPKMEPHX2MAPTHTT
SCHEMBL13452310 0.84 LMNA (0.45) GAAHTTKMT2ALMNAALDH1A1
SCHEMBL12900168 0.84 GAA (0.48) GAAPKMEPHX2MAPTHTT
SCHEMBL1268492 0.83 GAA (0.45) GAAPKMEPHX2MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
EP-1786782-B1 BISARYL-SULFONAMIDES AMGEN INC (US) 2010-03-31 — — EP disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
EP-1786782-A2 BISARYL-SULFONAMIDES Amgen Inc. (US) 2007-05-23 — — EP disclosed
US-20060084802-A1 Bisaryl-sulfonamides AMGEN INC. 2006-04-20 — — US disclosed
WO-2006020830-A2 BISARYL-SULFONAMIDES AMGEN INC. (US) 2006-02-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221584-A1 Bisaryl-sulfonamides PPARD, PPARA, PPARG GAA 1704/4885PKM 3049/4885EPHX2 1942/4885
US-20060084802-A1 Bisaryl-sulfonamides PPARD, PPARA, PPARG GAA 1704/4885PKM 3049/4885EPHX2 1942/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback